Peru: INS Resumes Administrative Procedures
June 2, 2020
On May 6, 2020, Peru’s National Institute of Health (Instituto Nacional de Salud (INS)) issued Communique 004-2020-OGITT/INS, which notes that the administrative procedures suspended by Communique 003-2020-OGITT/INS have been resumed.
All procedures related to COVID-19 do not have a cost. However, requests for authorization of clinical trials and their modifications not related to COVID-19, must have fees paid in compliance with applicable regulatory requirements. (Google translation of Communique 004-2020-OGITT/INS)